Status:
COMPLETED
Tertiary Lymphoid Structures Related Genes Predicting Prognosis in Clear Cell Renal Cell Carcinoma: a Retrospective Cohort Study
Lead Sponsor:
Ding-Wei Ye
Conditions:
Renal Cell Carcinoma (RCC)
Eligibility:
All Genders
Brief Summary
The purpose of this research was to uncover the prognostic significance of tertiary lymphoid structures related genes from ccRCC patients with respect to clinical characteristics and outcomes. This of...
Eligibility Criteria
Inclusion
- patients diagnosed with renal cell carcinoma
Exclusion
- incomplete medical records, inadequate follow-up information, and confirmed non-prostatic acinar adenocarcinoma
Key Trial Info
Start Date :
June 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 31 2025
Estimated Enrollment :
232 Patients enrolled
Trial Details
Trial ID
NCT06883565
Start Date
June 1 2024
End Date
January 31 2025
Last Update
March 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fudan University Shanghai Cancer Center
Shanghai, China